PEGASUS ASSET MANAGEMENT, INC. – Edwards Lifesciences Corporation Transaction History
PEGASUS ASSET MANAGEMENT, INC. portfolio value:
$3.43M
portfolio value
PEGASUS ASSET MANAGEMENT, INC. quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.31% | -552 shares | -570K | $82.63 | 41.55K |
| Q2 2022 | share | Decrease | -2.85% | -1.23K shares | -1.09M | $95.09 | 42.10K |
| Q1 2022 | share | Decrease | -0.81% | -354 shares | -559K | $117.72 | 43.34K |
| Q4 2021 | share | Increase | +0.56% | 243 shares | 742K | $130.68 | 43.69K |
| Q3 2021 | share | Decrease | -0.06% | -25 shares | 416K | $113.21 | 43.45K |
| Q2 2021 | share | Decrease | -0.48% | -209 shares | 849K | $103.57 | 43.47K |
| Q1 2021 | share | Increase | +3.36% | 1.41K shares | -202K | $83.64 | 43.68K |
| Q4 2020 | share | Increase | +0.11% | 45 shares | 486K | $91.23 | 42.26K |
| Q3 2020 | share | Increase | +0.24% | 101 shares | 459K | $79.82 | 42.22K |
| Q2 2020 | share | Decrease | -0.54% | -230 shares | 248K | $69.11 | 42.12K |
| Q1 2020 | share | Increase | +1.09% | 456 shares | -595K | $62.87 | 42.35K |
| Q4 2019 | share | Decrease | -1.34% | -567 shares | 145K | $77.76 | 41.89K |
| Q3 2019 | share | Increase | +0.30% | 129 shares | 506K | $73.3 | 42.46K |
| Q2 2019 | share | Decrease | -0.04% | -15 shares | -94K | $61.58 | 42.33K |
| Q1 2019 | share | Decrease | -1.53% | -660 shares | 505K | $63.78 | 42.34K |
| Q4 2018 | share | Decrease | -0.49% | -210 shares | -312K | $51.06 | 43.00K |
| Q3 2018 | share | Increase | +7.08% | 2.85K shares | 550K | $58.03 | 43.21K |
| Q2 2018 | share | Increase | +5.53% | 2.11K shares | 179K | $48.52 | 40.36K |
| Q1 2018 | share | Decrease | -1.62% | -630 shares | 318K | $46.51 | 38.24K |
| Q4 2017 | share | Increase | 0.00% | 38.87K shares | 1.46M | $37.57 | 38.87K |